VVTM — VVT Med Cashflow Statement
0.000.00%
Last trade - 00:00- CA$15.34m
- CA$16.98m
- $0.09m
Annual cashflow statement for VVT Med, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | Final |
| Net Income/Starting Line | -0.194 | -0.106 | -0.136 | -0.115 | -3.98 |
| Depreciation | |||||
| Non-Cash Items | 0 | — | — | — | 0.896 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.058 | 0.02 | 0.067 | 0.042 | -0.233 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -0.135 | -0.086 | -0.069 | -0.073 | -3.16 |
| Capital Expenditures | 0 | — | — | — | -0.004 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 0 | — | — | — | -0.004 |
| Financing Cash Flow Items | 0 | — | — | — | 2.23 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.092 | 0.085 | 0.074 | 0.073 | 3.03 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.043 | -0.002 | 0.005 | 0 | 0.041 |